Hester Biosciences Ltd.

NSE: HESTERBIO | BSE: 524669 | ISIN: INE782E01017 | Industry: Pharmaceuticals
| Mid-range Performer
1963.9000 -14.20 (-0.72%)
NSE Sep 24, 2025 13:57 PM
Volume: 1,472
 

1963.90
-0.72%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Standalone revenues grew 20% YoY in H1FY19 to | 80.8 crore on the back of 36% growth in the large animal segment to | 14.8 crore and addition of veterinary social business. The poultry segment grew 10% YoY in H1FY19 to | 62.3 crore EBITDA margins remained healthy at 38% in H1FY19. EBITDA grew 18% YoY in H1FY19 to | 30.5 crore Net profit grew 30% YoY to | 19.6 in H1FY19 crore mainly due to a...
Hester Biosciences Ltd. is trading above its 200 day SMA of 1905.1
More from Hester Biosciences Ltd.
Recommended